According to Takeda Pharmaceutical's latest financial reports the company's total liabilities are $54.36 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-03-31 | $57.07 B | -7.07% |
2022-03-31 | $61.41 B | -12.41% |
2021-03-31 | $70.12 B | -6.4% |
2020-03-31 | $74.91 B | -4.52% |
2019-03-31 | $78.46 B | 299.29% |
2018-03-31 | $19.65 B | -8.74% |
2017-03-31 | $21.53 B | 33.46% |
2016-03-31 | $16.13 B | -7.36% |
2015-03-31 | $17.41 B | -11.67% |
2014-03-31 | $19.71 B | 7.31% |
2013-03-31 | $18.37 B | 1.16% |
2012-03-31 | $18.16 B | 132.44% |
2011-03-31 | $7.81 B | 10.97% |
2010-03-31 | $7.04 B | -1.34% |
2009-03-31 | $7.13 B | 35.29% |
2008-03-31 | $5.27 B | 1.61% |
2007-03-31 | $5.19 B | -11.89% |
2006-03-31 | $5.89 B | 16.04% |
2005-03-31 | $5.07 B | -4.6% |
2004-03-31 | $5.32 B | 27.76% |
2003-03-31 | $4.16 B | 9.78% |
2002-03-31 | $3.79 B | -3.44% |
2001-03-31 | $3.92 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $115.27 B | 112.04% | ๐บ๐ธ USA |
![]() Novartis NVS | $59.04 B | 8.61% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $120.87 B | 122.34% | ๐บ๐ธ USA |
![]() Amgen AMGN | $83.48 B | 53.57% | ๐บ๐ธ USA |
![]() Sanofi SNY | $56.95 B | 4.76% | ๐ซ๐ท France |
![]() Merck MRK | $65.72 B | 20.90% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $59.66 B | 9.76% | ๐ฌ๐ง UK |
![]() Seagen
SGEN | $0.87 B | -98.39% | ๐บ๐ธ USA |
![]() Dr. Reddy's RDY | $1.09 B | -97.99% | ๐ฎ๐ณ India |